Or...Enter your Email


Useful Sites




Are you currently insured?
Yes No
First Name:
Last Name:
Zip Code:

  • National Debt Clock






Perrigo Company - Targeted Recommendations

Source: http://www.zacks.com/
Posted on Thursday, September 18th, 2008 | In Stocks to Watch
Contributed by: Alex Kolb (http://www.zacks.com/) -

Perrigo Company (PRGO) is the nation’s largest manufacturer of store brand over-the-counter (non-prescription) pharmaceutical products, and it manufactures store brand nutritional products.

Perrigo enjoyed strong upward momentum this week, ascending 7.33% Thursday after Wednesday’s 2.93% gain and a 3.60% increase on Tuesday. The company was the subject of an analyst upgrade a few days ago.

Prior to the upgrade, PRGO announced that it acquired drug and nutritional products maker JB Laboratories for about $44 million in cash. The company mentioned that the acquisition is expected to add more than $70 million of annual sales.

Perrigo announced record fiscal fourth-quarter results in mid-August. The company’s profit increased by 46% thanks to the hike seen in demand for its consumer health care products.

Record net sales of $500.2 million jumped 34% year-over-year, while net income of $27.5 million climbed from last year’s $18.8 million.

Management noted that this was the third consecutive quarter of year-over year-record sales and earnings, adding that the company also generated $248 million in cash from operations for the year.

Perrigo’s Chairman and CEO Joseph C. Papa said, “our team is executing well — growing market share, managing our supply chain and delivering strong returns. And by bringing innovative new products to market, we continue to make quality healthcare more affordable at a time when consumers need to save money more than ever. We continue to invest in research and development, building our pipeline for future innovation as well.”

The company’s earnings outlook for the full fiscal year 2009 stands at $1.90 to $1.98 per share. Wall Street hiked the fiscal year projection on strong quarterly results. Current forecasts of $1.92 per share are above last month’s $1.91.

Company Ticker One-Week
Return

Perrigo Company PRGO 11.79%

Psychiatric Sol PSYS 4.51%

Columbus Mckinn CMCO 2.69%

Kansas City Sou KSU 1.91%

Mcdonalds Corp MCD -0.16%

“PRGO” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research

Last 5 posts by Alex Kolb





About Alex Kolb (http://www.zacks.com/)
Alex Kolb is an Editor at Zacks Investment Research.

Leave a Reply

Name

Email (kept private)

Website




Custom Search







Related Posts

»Barron’s Analyst Recommends Perrigo
»Perrigo (PRGO) Gets FDA Approval For Nicotine Gum
»Perrigo Co. - Growth & Income - Zacks Rank Buy

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.